clinical trial endpoints
9
triples
GPTKB property
Random triples
| Subject | Object |
|---|---|
| gptkb:Uro_Gen's_RTGel | overall survival |
| gptkb:Tessa_Therapeutics | overall survival and response rate |
| gptkb:Golodirsen | safety assessment |
| gptkb:Tendyne | safety and efficacy |
| gptkb:TCR_Therapeutics | primary and secondary endpoints. |
| gptkb:CTX120 | primary and secondary endpoints defined |
| gptkb:Golodirsen | biomarker analysis |
| gptkb:Lilly's_COVID-19_antibody_treatment | reduction in viral load |
| gptkb:Golodirsen | muscle function improvement |